Pharmaceutical Supply – Ophthalmic Antibiotic Solution

The contract outlines the supply and delivery of 81 bottles of Ciprofloxacin Hydrochloride Ophthalmic Solution, identified by NDC61314-0656-05 and NSN 6505013519272, specifically for use within U.S. military medical facilities. The product must fully comply with all applicable FDA regulations as well as the National Drug Code and NATO Stock Number standards to ensure proper classification, traceability, and regulatory approval for military deployment. The contract is structured as a subcontract under the Defense Logistics Agency, which operates under the Department of Defense, and is tied to the NAICS code 325412, indicating pharmaceutical manufacturing as the relevant industry classification. The award is linked to active contract and delivery identifiers indicating ongoing logistics coordination, with the posting date set for August 5, 2026, suggesting this is part of a forward-planned procurement cycle to maintain medical readiness. The place of performance and point of contact details are unspecified, but the execution is governed through the DLA’s procurement system, ensuring standardized military supply chain protocols are followed.